Novitas, the US Medicare Administrative Contractor, delays making final decision on removing Cxbladder from its approved test list.
JNL starting to feel pain from early forest felling in Northland; Shane Jones promises to step in.
The tit-for-tat intellectual property battle with ResMed continues.
Updated: The electricity pricing review prepares for consultation.
However, Apple shares dropped 1.8%, giving up their premarket gains.
Entrepreneur series: Ceres Organics co-founder Noel Josephson says he never gets tempted to do anything else.
News media are being advised to cut back on social networking.
The Dust Palace equity crowdfunds its expansion.
Consultation will extend over the Christmas and summer break
Index-hugging is backward looking and leads to value traps.